Top Markets
Coin of the day
AnnJi AnnJi

AnnJi

7754
株式のランク #18685
Founded in 2014 and headquartered in Taipei, Taiwan, AnnJi Pharmaceutical Co.,... Founded in 2014 and headquartered in Taipei, Taiwan, AnnJi Pharmaceutical Co., Ltd. specializes in the creation of innovative medicinal treatments. The company's research and development pipeline addresses neurological, dermatological, and inflammatory conditions. Among its key therapeutic candidates are AJ201, which is being developed for the neurodegenerative disorder spinal and bulbar muscular atrophy, and AJ202, targeting androgenetic alopecia. AnnJi also works on AJ302, a histone deacetylase 6 inhibitor aimed at preventing and treating chemotherapy-induced peripheral neuropathy, and AJ303, an anti-fibrotic and anti-inflammatory agent intended for idiopathic pulmonary fibrosis and other fibrotic diseases.
株価
$1.88
時価総額
$190.02M
変化(1日)
0.51%
変化(1年)
24.67%
TW
取引 AnnJi (7754)

カテゴリー

AnnJi(7754)の配当利回りの履歴
AnnJi(銘柄コード: 7754)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
AnnJi(7754)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)